Current guidance
29 items
Each item compared with the same item in the previous release (May 7, 2026). Values in quotation marks are the company’s words.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| New | Net Sales | for Q2 FY2027 | — | “$1.589 to $1.618 billion” | Filing ↗ |
| New | Diluted net income per common share - GAAP | for Q2 FY2027 | — | “$0.53 to $0.54” | Filing ↗ |
| New | Diluted net income per common share - Non-GAAP | for Q2 FY2027 | — | “$0.91 to $0.95” | Filing ↗ |
| New | Diluted net income per common share - Non-GAAP Adjustments | for Q2 FY2027 | — | “$0.38 to $0.41” | Filing ↗ |
| New | Gross Profit - GAAP | for Q2 FY2027 | — | “65.4% to 66.3%” | Filing ↗ |
| New | Gross Profit - Non-GAAP | for Q2 FY2027 | — | “66.0% to 67.0%” | Filing ↗ |
| New | Gross Profit - Non-GAAP Adjustments | for Q2 FY2027 | — | “$10.3 to $11.3 million” | Filing ↗ |
| New | Net income - GAAP | for Q2 FY2027 | — | “$321.0 to $323.0 million” | Filing ↗ |
| New | Net income - Non-GAAP Adjustments | for Q2 FY2027 | — | “$199.0 to $223.4 million” | Filing ↗ |
| New | Net income attributable to common stockholders - GAAP | for Q2 FY2027 | — | “$293.2 to $295.2 million” | Filing ↗ |
| New | Net income attributable to common stockholders - Non-GAAP | for Q2 FY2027 | — | “$520.0 to $546.4 million” | Filing ↗ |
| New | Net income attributable to common stockholders - Non-GAAP Adjustments | for Q2 FY2027 | — | “$226.8 to $251.2 million” | Filing ↗ |
| New | Operating Income - GAAP | for Q2 FY2027 | — | “28.1% to 28.9%” | Filing ↗ |
| New | Operating Income - Non-GAAP | for Q2 FY2027 | — | “38.5% to 39.5%” | Filing ↗ |
| New | Operating Income - Non-GAAP Adjustments | for Q2 FY2027 | — | “$166.0 to $171.0 million” | Filing ↗ |
| New | Diluted Common Shares Outstanding - GAAP | for Q2 FY2027 | — | “Approximately 550.7 to 551.7 million shares” | Filing ↗ |
| New | Diluted Common Shares Outstanding - Non-GAAP | for Q2 FY2027 | — | “Approximately 574.5 to 575.5 million shares” | Filing ↗ |
| New | Diluted Common Shares Outstanding - Non-GAAP Adjustments | for Q2 FY2027 | — | “23.8 million shares” | Filing ↗ |
| New | Dividends on Series A Preferred Stock - Non-GAAP Adjustments | for Q2 FY2027 | — | “$27.8 million” | Filing ↗ |
| New | Income Tax Provision - GAAP | for Q2 FY2027 | — | “$75.3 to $96.5 million” | Filing ↗ |
| New | Income Tax Provision - Non-GAAP | for Q2 FY2027 | — | “$42.2 to $44.3 million” | Filing ↗ |
| New | Income Tax Provision - Non-GAAP Adjustments | for Q2 FY2027 | — | “$(52.2) to $(33.1) million” | Filing ↗ |
| New | Operating Expenses - GAAP | for Q2 FY2027 | — | “37.3% to 37.4%” | Filing ↗ |
| New | Operating Expenses - Non-GAAP | for Q2 FY2027 | — | “27.5%” | Filing ↗ |
| New | Operating Expenses - Non-GAAP Adjustments | for Q2 FY2027 | — | “$155.7 to $159.7 million” | Filing ↗ |
| New | Other Expense, net - GAAP | for Q2 FY2027 | — | “$48.7 to $49.3 million” | Filing ↗ |
| New | Other Expense, net - Non-GAAP | for Q2 FY2027 | — | “$48.5 to $49.5 million” | Filing ↗ |
| New | Other Expense, net - Non-GAAP Adjustments | for Q2 FY2027 | — | “$(0.2) to $0.2 million” | Filing ↗ |
| New | Net sales for the September quarter | No period stated | — | “up sequentially between 7% and 9%” | Filing ↗ |
| New | Net sales sequential growth | No period stated | — | “up sequentially between 7% and 9%” | Filing ↗ |
| New | Net sales year-over-year growth (at midpoint) | No period stated | — | “approximately 40.6%” | Filing ↗ |
| Reiterated | Capital expenditures | for FY2027 | “approximately $100 million” | “approximately $100 million” | Filing ↗ |
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Net sales | No period stated | “$1.442 billion to $1.469 billion” | — | Filing ↗ |
| Not restated | Non-GAAP gross margin | No period stated | “approximately 62.25% to 63.25%” | — | Filing ↗ |
| Not restated | Non-GAAP operating profit | No period stated | “33.00% to 34.50%” | — | Filing ↗ |
| Not restated | Non-GAAP operating expense | No period stated | “approximately 28.75% to 29.25%” | — | Filing ↗ |
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Net Sales | “$1.589 to $1.618 billion” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Diluted net income per common share - GAAP | “$0.53 to $0.54” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Diluted net income per common share - Non-GAAP | “$0.91 to $0.95” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Diluted net income per common share - Non-GAAP Adjustments | “$0.38 to $0.41” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Gross Profit - GAAP | “65.4% to 66.3%” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Gross Profit - Non-GAAP | “66.0% to 67.0%” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Gross Profit - Non-GAAP Adjustments | “$10.3 to $11.3 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Net income - GAAP | “$321.0 to $323.0 million” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Net income - Non-GAAP Adjustments | “$199.0 to $223.4 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Net income attributable to common stockholders - GAAP | “$293.2 to $295.2 million” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Net income attributable to common stockholders - Non-GAAP | “$520.0 to $546.4 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Net income attributable to common stockholders - Non-GAAP Adjustments | “$226.8 to $251.2 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Income - GAAP | “28.1% to 28.9%” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Income - Non-GAAP | “38.5% to 39.5%” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Income - Non-GAAP Adjustments | “$166.0 to $171.0 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Capital expenditures | “approximately $100 million” | for FY2027 | Company-defined | May 7, 2026 | 2 | Filing ↗ |
| Diluted Common Shares Outstanding - GAAP | “Approximately 550.7 to 551.7 million shares” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Diluted Common Shares Outstanding - Non-GAAP | “Approximately 574.5 to 575.5 million shares” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Diluted Common Shares Outstanding - Non-GAAP Adjustments | “23.8 million shares” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Dividends on Series A Preferred Stock - Non-GAAP Adjustments | “$27.8 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Income Tax Provision - GAAP | “$75.3 to $96.5 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Income Tax Provision - Non-GAAP | “$42.2 to $44.3 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Income Tax Provision - Non-GAAP Adjustments | “$(52.2) to $(33.1) million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Expenses - GAAP | “37.3% to 37.4%” | for Q2 FY2027 | GAAP-tied | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Expenses - Non-GAAP | “27.5%” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Operating Expenses - Non-GAAP Adjustments | “$155.7 to $159.7 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Other Expense, net - GAAP | “$48.7 to $49.3 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Other Expense, net - Non-GAAP | “$48.5 to $49.5 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Other Expense, net - Non-GAAP Adjustments | “$(0.2) to $0.2 million” | for Q2 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Quarterly cash dividend | “45.5 cents per share” | — | Declared action | May 7, 2026 | 1 | Filing ↗ |
| Quarterly cash dividend on 7.50% Series A Mandatory Convertible Preferred Stock | “$18.750 per share” | — | Declared action | May 8, 2025 | 3 | Filing ↗ |
| Quarterly cash dividend on Microchip's 7.50% Series A Mandatory Convertible Preferred Stock | “$18.750 per share” | — | Declared action | Aug 6, 2026 | 1 | Filing ↗ |
| Quarterly dividend | “45.5 cents per share” | — | Declared action | Nov 5, 2024 | 3 | Filing ↗ |
| Quarterly dividend declared | “45.5 cents per share” | — | Declared action | Feb 6, 2025 | 1 | Filing ↗ |
| Quarterly dividend on common stock | “45.5 cents per share” | — | Declared action | Nov 6, 2025 | 2 | Filing ↗ |
| Quarterly dividend on common stock declared for the June quarter | “45.5 cents per share” | — | Declared action | May 8, 2025 | 1 | Filing ↗ |
Capital expenditures, for FY2025 — every statement across the year, each linked to its filing.
12 companies in Semiconductors. What they guide on, and who reported this season.
| Micron Technology | Sep 30, 2026 | 7 changes |
| Broadcom | Sep 2, 2026 | 6 changes |
| Marvell Technology | Aug 27, 2026 | 11 changes |
| Nvidia | Aug 26, 2026 | 6 changes |
| Analog Devices | Aug 19, 2026 | 8 changes |
| Microchip Technology | Aug 6, 2026 | 31 changes |
| AMD | Aug 4, 2026 | 10 changes |
| Onsemi | Aug 3, 2026 | 15 changes |
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2027 | FY2026 | FY2025 | FY2024 | No period |
|---|---|---|---|---|---|
| Expected net sales | — | — | 1 statement | — | — |
| GAAP Gross Profit (% of net sales) | 2 statements | 3 statements | 2 statements | — | — |
| GAAP Operating Expenses (% of net sales) | 2 statements | 3 statements | 2 statements | — | — |
| GAAP Operating Income (% of net sales) | 2 statements | 3 statements | 2 statements | — | — |
| Net Sales | 2 statements | 4 statements | 2 statements | — | 1 statement |
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Aug 6, 2026 | FY2027 Q1 | 0000827054-26-000037 | 36 | Open filing ↗ |
| May 7, 2026 | FY2026 Q4 | 0000827054-26-000012 | 31 | Open filing ↗ |
| Jan 5, 2026 | FY2026 Q3 | 0000827054-26-000002 | 1 | Open filing ↗ |
| Nov 6, 2025 | FY2026 Q2 | 0000827054-25-000182 | 25 | Open filing ↗ |
| Aug 7, 2025 | FY2026 Q1 | 0000827054-25-000132 | 27 | Open filing ↗ |
| May 8, 2025 | FY2025 Q4 | 0000827054-25-000061 | 27 | Open filing ↗ |
| Feb 6, 2025 | FY2025 Q3 | 0000827054-25-000018 | 20 | Open filing ↗ |
| Nov 5, 2024 | FY2025 Q2 | 0000827054-24-000205 | 21 | Open filing ↗ |